abstract |
The present invention provides cell proliferation inhibitors and cell proliferation inhibitors useful for the treatment of diseases, particularly cancer, based on aberrant proliferation of cells, and relates to cell proliferation inhibitors comprising an anti-glycancan tribody as an active ingredient. |